Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast
- 1 September 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 122, 64-76
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Lung penetration and patient adherence considerations in the management of asthma: role of extra fine formulationsJournal of Asthma and Allergy, 2013
- Microencapsulation of bioactives in cross-linked alginate matrices by spray dryingJournal of Microencapsulation, 2012
- Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsLung Cancer, 2012
- Roflumilast inhibits the release of chemokines and TNF‐α from human lung macrophages stimulated with lipopolysaccharideBritish Journal of Pharmacology, 2011
- The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticlesBiomaterials, 2011
- Chemical, physical and biological properties of alginates and their biomedical implicationsFood Hydrocolloids, 2011
- Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) Self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheresInternational Journal of Pharmaceutics, 2010
- Swellable microparticles as carriers for sustained pulmonary drug deliveryJournal of Pharmaceutical Sciences, 2010
- Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPDThorax, 2007
- COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinomaThorax, 2004